COVID-19 convalescent plasma Terminated Phase 3 Trials for COVID / Infectious Diseases / Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04361253Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy